Cargando…
Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer’s Disease and Frontotemporal Dementia
Alzheimer’s disease (AD) is the primary type of dementia, followed by frontotemporal lobar degeneration (FTLD). They share some clinical characteristics, mainly at the early stages. So, the identification of early, specific, and minimally invasive biomarkers is required. In this study, some plasma b...
Autores principales: | Álvarez-Sánchez, Lourdes, Peña-Bautista, Carmen, Ferré-González, Laura, Balaguer, Angel, Baquero, Miguel, Casanova-Estruch, Bonaventura, Cháfer-Pericás, Consuelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864037/ https://www.ncbi.nlm.nih.gov/pubmed/36674742 http://dx.doi.org/10.3390/ijms24021226 |
Ejemplares similares
-
Early Alzheimer’s Disease Screening Approach Using Plasma Biomarkers
por: Álvarez-Sánchez, Lourdes, et al.
Publicado: (2023) -
Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer’s Disease
por: Peña-Bautista, Carmen, et al.
Publicado: (2020) -
Assessment of Lipid Peroxidation in Alzheimer’s Disease Differential Diagnosis and Prognosis
por: Ferré-González, Laura, et al.
Publicado: (2022) -
Assessment of Screening Approach in Early and Differential Alzheimer’s Disease Diagnosis
por: Ferré-González, Laura, et al.
Publicado: (2021) -
Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages
por: Peña-Bautista, Carmen, et al.
Publicado: (2021)